Compare Novartis with CRAVATEX - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS vs CRAVATEX - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NOVARTIS CRAVATEX NOVARTIS/
CRAVATEX
 
P/E (TTM) x 85.3 -3.0 - View Chart
P/BV x 2.7 3.7 72.9% View Chart
Dividend Yield % 1.3 0.8 150.8%  

Financials

 NOVARTIS   CRAVATEX
EQUITY SHARE DATA
    NOVARTIS
Mar-21
CRAVATEX
Mar-20
NOVARTIS/
CRAVATEX
5-Yr Chart
Click to enlarge
High Rs770550 140.1%   
Low Rs501260 192.7%   
Sales per share (Unadj.) Rs154.53,018.1 5.1%  
Earnings per share (Unadj.) Rs8.5-33.1 -25.5%  
Cash flow per share (Unadj.) Rs13.418.8 71.1%  
Dividends per share (Unadj.) Rs10.003.00 333.3%  
Avg Dividend yield %1.60.7 212.4%  
Book value per share (Unadj.) Rs289.295.6 302.6%  
Shares outstanding (eoy) m24.692.58 957.0%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x4.10.1 3,062.2%   
Avg P/E ratio x75.1-12.2 -613.5%  
P/CF ratio (eoy) x47.521.5 220.4%  
Price / Book Value ratio x2.24.2 51.8%  
Dividend payout %118.1-9.1 -1,302.9%   
Avg Mkt Cap Rs m15,6911,046 1,499.7%   
No. of employees `000NANA-   
Total wages/salary Rs m1,085614 176.9%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m3,8147,787 49.0%  
Other income Rs m33252 634.6%   
Total revenues Rs m4,1467,839 52.9%   
Gross profit Rs m267118 226.4%  
Depreciation Rs m122134 90.7%   
Interest Rs m77115 66.5%   
Profit before tax Rs m400-79 -504.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1916 3,142.9%   
Profit after tax Rs m209-86 -244.4%  
Gross profit margin %7.01.5 462.3%  
Effective tax rate %47.8-7.7 -623.8%   
Net profit margin %5.5-1.1 -499.1%  
BALANCE SHEET DATA
Current assets Rs m9,2242,740 336.6%   
Current liabilities Rs m3,5731,972 181.2%   
Net working cap to sales %148.29.9 1,501.4%  
Current ratio x2.61.4 185.8%  
Inventory Days Days17617 1,014.6%  
Debtors Days Days3755 67.2%  
Net fixed assets Rs m2,480851 291.3%   
Share capital Rs m12326 477.6%   
"Free" reserves Rs m7,018221 3,178.7%   
Net worth Rs m7,141247 2,895.7%   
Long term debt Rs m0833 0.0%   
Total assets Rs m11,7033,591 325.9%  
Interest coverage x6.20.3 1,989.8%   
Debt to equity ratio x03.4 0.0%  
Sales to assets ratio x0.32.2 15.0%   
Return on assets %2.40.8 292.6%  
Return on equity %2.9-34.7 -8.4%  
Return on capital %6.73.3 200.0%  
Exports to sales %9.30-   
Imports to sales %00-   
Exports (fob) Rs m354NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m35427 1,324.7%   
Fx outflow Rs m9740-   
Net fx Rs m-62127 -2,325.6%   
CASH FLOW
From Operations Rs m-692620 -111.6%  
From Investments Rs m952-732 -130.0%  
From Financial Activity Rs m-368432 -85.1%  
Net Cashflow Rs m-109321 -33.8%  

Share Holding

Indian Promoters % 0.0 75.0 -  
Foreign collaborators % 73.4 0.0 -  
Indian inst/Mut Fund % 1.3 0.8 176.3%  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 26.6 25.0 106.4%  
Shareholders   44,652 2,373 1,881.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NOVARTIS With:   EVEXIA LIFECARE  GAGAN POLYCOT  ASHNISHA INDUSTRIES  MRC EXIM   GLOBE COMMERCIALS  



Today's Market

Sensex Rises 200 Points, Nifty Tops 18,350; Sun Pharma and ONGC Top Gainers(09:30 am)

Asian share markets are mixed today as rising US bond yields worried investors, although overnight gains on Wall Street provided some support.

Related Views on News

NOVARTIS Announces Quarterly Results (3QFY20); Net Profit Down 39.9% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, NOVARTIS has posted a net profit of Rs 77 m (down 39.9% YoY). Sales on the other hand came in at Rs 1 bn (down 13.4% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

NOVARTIS Announces Quarterly Results (3QFY20); Net Profit Down 39.9% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, NOVARTIS has posted a net profit of Rs 77 m (down 39.9% YoY). Sales on the other hand came in at Rs 1 bn (down 13.4% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

More Views on News

Most Popular

Is it Time to Switch from Tata Power to NTPC?(Profit Hunter)

Oct 11, 2021

Given the huge run up in Tata Power, does it make sense to switch to NTPC?

This Proxy EV Stock Just got a Power Crisis Boost(Profit Hunter)

Oct 8, 2021

After months of research, I've come across few stocks that excite me far more than the mainstream electric vehicle companies.

Rs 1 Lakh Invested in These Cryptos at the Start of 2021 Became Rs...(Views On News)

Oct 8, 2021

These cryptos would have multiplied investors' wealth by as much as 10,000% in just nine months.

Modi's Big Move Could Boost these 5 Defence Stocks(Views On News)

Oct 11, 2021

To corporatise the defence sector, the Ministry of Defence (MoD) has dissolved the 250-year-old Ordnance Factory Board (OFB).

5 Green Energy Stocks to Watch as India Readies for a Revolution(Views On News)

Oct 13, 2021

The excitement around green energy stocks has opened up a huge contrarian opportunity in the traditional energy space.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

NOVARTIS SHARE PRICE


Oct 21, 2021 09:56 AM

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NOVARTIS 8-QTR ANALYSIS

COMPARE NOVARTIS WITH

MARKET STATS